Back to search

Exploratory analyses EGFR, kRAS mutations and other molecular markers in tumors of NSCLC patients (pts) treated with chemotherapy +/- erlotinib (TALENT)

U. Gatzemeier, Adi Heller, Dorothee Foernzler, Joachim Moecks, Corrine Ward
DOI: 10.1200/jco.2005.23.16_suppl.7028
Journal of Clinical Oncology

Data up to Jan 2025

Published2005
Citations41
References0
Fields
MedicineBiologyOncologyInternal medicineCancer research

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

Loading...
Exploratory analyses EGFR, kRAS mutations and other molecular markers in tumors of NSCLC… (2005) – Journal of Clinical Oncology | Metascience Observatory Explorer